デフォルト表紙
市場調査レポート
商品コード
1738426

ビタミンB12市場- 世界の産業規模、シェア、動向、機会、予測、販売チャネル別、最終用途別、地域別、競合別セグメント、2020-2030年

Vitamin B12 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
ビタミンB12市場- 世界の産業規模、シェア、動向、機会、予測、販売チャネル別、最終用途別、地域別、競合別セグメント、2020-2030年
出版日: 2025年05月30日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

ビタミンB12の世界市場は、2024年には1億6,509万米ドルとなり、2030年には1億9,902万米ドルに達し、CAGR 2.58%で成長すると予測されています。

コバラミンとして知られるビタミンB12は、赤血球の生産、神経の健康、DNA合成に不可欠な役割を果たしています。疲労、貧血、神経障害の予防におけるコバラミン摂取の重要性に対する意識の高まりが、様々な層におけるサプリメント摂取の増加を促進しています。植物性食生活を送る人々は特に欠乏症のリスクが高く、その結果、シリアル、エネルギー飲料、植物性ミルクなどの栄養強化製品に対する需要が高まっています。さらに、栄養吸収能力が低下した高齢化社会が、臨床栄養ソリューションの需要をさらに高めています。医薬品や栄養補助食品の処方におけるビタミンB12の使用拡大は、健康維持や疾病管理、特に認知や疲労に関連する症状におけるビタミンB12の役割の進化を浮き彫りにしています。

市場概要
予測期間 2026-2030
市場規模：2024年 1億6,509万米ドル
市場規模：2030年 1億9,902万米ドル
CAGR：2025年～2030年 2.58%
急成長セグメント ダイレクト
最大市場 北米

市場促進要因

製薬業界の成長

主な市場課題

高い生産コスト

主な市場動向

栄養補助食品用途の拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のビタミンB12市場に与える影響

第5章 世界のビタミンB12市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 販売チャネル別（直接、間接）
    • 用途別（医薬品、飼料、食品・飲料、ヘルスケア、パーソナルケア、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米のビタミンB12市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のビタミンB12市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のビタミンB12市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のビタミンB12市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのビタミンB12市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 世界のビタミンB12市場：SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Hebei Yuxing Bio-Engineering Co., Ltd.
  • Hebei Huarong Pharmaceutical Co., Ltd
  • North China Pharmaceutical Group Corp.（NCPC）
  • Ningxia Kingvit Pharmaceutical CO.,LTD
  • Euroapi
  • DSM

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 29291

The Global Vitamin B12 Market was valued at USD 165.09 Million in 2024 and is projected to reach USD 199.02 Million by 2030, growing at a CAGR of 2.58%. Known as cobalamin, Vitamin B12 plays an essential role in red blood cell production, nerve health, and DNA synthesis. Rising awareness of its importance in preventing fatigue, anemia, and neurological disorders is driving increased supplementation across various demographic groups. Individuals following plant-based diets are especially at risk for deficiency, resulting in a growing demand for fortified products such as cereals, energy drinks, and plant-based milk. Additionally, an aging population with reduced nutrient absorption capacity further fuels demand for clinical nutrition solutions. The expanding use of Vitamin B12 in pharmaceutical and nutraceutical formulations highlights its evolving role in health maintenance and disease management, particularly for cognitive and fatigue-related conditions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 165.09 Million
Market Size 2030USD 199.02 Million
CAGR 2025-20302.58%
Fastest Growing SegmentDirect
Largest MarketNorth America

Key Market Drivers

Growth in Pharmaceutical Industry

The continued expansion of the pharmaceutical sector is a major growth driver for the Vitamin B12 market. With global pharmaceutical revenues reaching USD 1.6 trillion by 2023, the industry has become a key consumer of Vitamin B12, particularly in applications related to anemia, neurological health, and prenatal care. Vitamin B12 is indispensable for red blood cell formation, nervous system function, and DNA replication, making it a staple ingredient in a variety of pharmaceutical products. Increased awareness about deficiencies-especially among vegetarians, the elderly, and individuals with absorption issues-has further accelerated demand. Companies like EUROAPI, which remains the only Western-based producer of Vitamin B12 for pharmaceutical use, continue to innovate with advanced fermentation technologies to meet global supply needs.

Key Market Challenges

High Production Costs

High production costs present a major challenge in the Vitamin B12 market. Manufacturing bioactive forms like methylcobalamin involves complex microbial fermentation processes and sophisticated purification methods. These procedures require stringent environmental controls and high operational precision, significantly driving up costs. Production yields can vary due to inconsistencies in microbial performance and raw material quality, leading to inefficiencies and wastage. Furthermore, maintaining product purity and stability demands advanced technology and rigorous quality control, particularly in regions with elevated labor and energy costs. These factors make large-scale production costly and reduce profitability for manufacturers, especially smaller enterprises.

Key Market Trends

Expansion of Nutraceutical Applications

The growing popularity of nutraceuticals is a key trend bolstering the Vitamin B12 market. Increasing consumer focus on preventive healthcare and overall wellness is driving demand for Vitamin B12 in functional foods and dietary supplements. In India, for instance, the government introduced fortified nutritional products like Jan Aushadhi Poshan under the PMBJP initiative, containing Vitamin B12 among other vital nutrients. B12's recognized benefits in energy production, cognitive health, and immune support are making it a popular addition to multivitamins, fortified drinks, and meal replacement formulas. With health-conscious lifestyles becoming more prevalent, especially in North America, Europe, and Asia-Pacific, manufacturers are actively expanding their nutraceutical product lines enriched with B12.

Key Market Players

  • Hebei Yuxing Bio-Engineering Co., Ltd.
  • Hebei Huarong Pharmaceutical Co., Ltd
  • North China Pharmaceutical Group Corp. (NCPC)
  • Ningxia Kingvit Pharmaceutical CO., LTD
  • Euroapi
  • DSM

Report Scope

In this report, the Global Vitamin B12 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B12 Market, By Sales Channel:

  • Direct
  • Indirect

Vitamin B12 Market, By End Use:

  • Pharmaceutical
  • Animal Feed
  • Food & Beverages
  • Healthcare
  • Personal Care
  • Others

Vitamin B12 Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B12 Market.

Available Customizations

Global Vitamin B12 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin B12 Market

5. Global Vitamin B12 Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Pharmaceutical, Animal Feed, Food & Beverages, Healthcare, Personal Care, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Vitamin B12 Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vitamin B12 Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Vitamin B12 Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Vitamin B12 Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Vitamin B12 Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Vitamin B12 Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Vitamin B12 Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Vitamin B12 Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Vitamin B12 Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Vitamin B12 Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B12 Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vitamin B12 Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Vitamin B12 Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Vitamin B12 Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Vitamin B12 Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Vitamin B12 Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Vitamin B12 Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Vitamin B12 Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Vitamin B12 Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Vitamin B12 Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin B12 Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Vitamin B12 Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Vitamin B12 Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Vitamin B12 Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vitamin B12 Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hebei Yuxing Bio-Engineering Co., Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Hebei Huarong Pharmaceutical Co., Ltd
  • 15.3. North China Pharmaceutical Group Corp. (NCPC)
  • 15.4. Ningxia Kingvit Pharmaceutical CO.,LTD
  • 15.5. Euroapi
  • 15.6. DSM

16. Strategic Recommendations

17. About Us & Disclaimer